{"success":true,"data":{"pressRelease":{"id":"81069","rtpr_id":"nPnjPV4Ma","ticker":"LABB","exchange":"","all_tickers":["LABB"],"title":"Genomma Lab Internacional S.A.B. de C.V. Second Quarter 2026 Earnings Results Conference Call","author":"PR Newswire","published_at":"2026-07-06T15:30:29.823Z","article_body":"Genomma Lab Internacional S.A.B. de C.V. Second Quarter 2026 Earnings Results Conference Call\n\nPR Newswire\n\nMEXICO CITY, July 6, 2026\n\nMEXICO CITY, July 6, 2026 /PRNewswire/ -- Genomma Lab Internacional, S.A.B. de\nC.V. (BMV: LABB) (\"Genomma Lab\" or \"the Company\") today announced that it\nwill report its Second Quarter 2026 Earnings Results on Wednesday, July 22,\n2026, after the Mexican Stock Exchange (BMV) close. The company also announced\nthat it will hold a conference call on Thursday, July 23, 2026, at 11 a.m.\nMexico City Time to discuss its quarterly financial results.\n\nPresenters: Marco Sparvieri, Chief Executive Officer\n             Antonio Zamora, Chief Financial Officer\n             Christianne Ibañez, Investor Relations Officer\n\nDate: Thursday, July 23, 2026\n\nTime: 11:00 a.m. (Mexico City Time)\n\nWebcast: To register please access via direct link\n(https://edge.prnewswire.com/c/link/?t=0&l=en&o=4725665-1&h=3574173557&u=https%3A%2F%2Fmymottion.zoom.us%2Fwebinar%2Fregister%2FWN_i5P3wxtQTkCLK8g-R3HL9Q%23%2Fregistration&a=access+via+direct+link)\n\n            (You will receive an email confirmation with an invitation)\n\nAbout Genomma Lab Internacional\n\nGenomma Lab Internacional, S.A.B. de C.V. is one of the leading pharmaceutical\nand personal care products companies in Mexico with an increasing\ninternational presence. Genomma Lab develops, sells and markets a broad range\nof premium branded products, many of which are leaders in the categories in\nwhich they compete in terms of sales and market share. Genomma Lab relies on\nthe combination of a successful new product development process, a\nconsumer-oriented marketing, a broad retail distribution network and a\nlow-cost, highly flexible operating model.\n\nGenomma Lab's shares are listed on the Mexican Stock Exchange under the ticker\n\"LAB B\" (Bloomberg: LABB:MM).\n\nNote on Forward-Looking Statements\n\nThis report may contain certain forward-looking statements and information\nrelating to the Company that reflect the current views and/or expectations of\nthe Company and its management with respect to its performance, business and\nfuture events. Forward looking statements include, without limitation, any\nstatement that may predict, forecast, indicate or imply future results,\nperformance or achievements, and may contain words like \"believe,\"\n\"anticipate,\" \"expect,\" \"envisages,\" \"will likely result,\" or any other words\nor phrases of similar meaning. Such statements are subject to a number of\nrisks, uncertainties and assumptions. We caution you that a number of\nimportant factors could cause actual results to differ materially from the\nplans, objectives, expectations, estimates and intentions expressed in this\npresentation and in oral statements made by authorized officers of the\nCompany. Readers are cautioned not to place undue reliance on these\nforward-looking statements, which speak only as of their dates. The Company\nundertakes no obligation to update or revise any forward-looking statements,\nwhether as a result of new information, future events or otherwise.\n\nView original\ncontent:https://www.prnewswire.com/news-releases/genomma-lab-internacional-sab-de-cv-second-quarter-2026-earnings-results-conference-call-302818485.html\n(https://www.prnewswire.com/news-releases/genomma-lab-internacional-sab-de-cv-second-quarter-2026-earnings-results-conference-call-302818485.html)\n\nSOURCE Genomma Lab Internacional, S.A.B. de C.V.\n\n\n\nInvestor Relations, T. +52 (55) 5081 0000, investor.relations@genommalab.com\n\nCopyright (c) 2026 PR Newswire Association,LLC. All Rights Reserved.","article_body_html":"","raw_payload":{"data":{"id":"nPnjPV4Ma","title":"Genomma Lab Internacional S.A.B. de C.V. Second Quarter 2026 Earnings Results Conference Call","author":"PR Newswire","ticker":"LABB","created":"2026-07-06T15:30:29.823Z","tickers":["LABB"],"exchange":"","article_body":"Genomma Lab Internacional S.A.B. de C.V. Second Quarter 2026 Earnings Results Conference Call\n\nPR Newswire\n\nMEXICO CITY, July 6, 2026\n\nMEXICO CITY, July 6, 2026 /PRNewswire/ -- Genomma Lab Internacional, S.A.B. de\nC.V. (BMV: LABB) (\"Genomma Lab\" or \"the Company\") today announced that it\nwill report its Second Quarter 2026 Earnings Results on Wednesday, July 22,\n2026, after the Mexican Stock Exchange (BMV) close. The company also announced\nthat it will hold a conference call on Thursday, July 23, 2026, at 11 a.m.\nMexico City Time to discuss its quarterly financial results.\n\nPresenters: Marco Sparvieri, Chief Executive Officer\n             Antonio Zamora, Chief Financial Officer\n             Christianne Ibañez, Investor Relations Officer\n\nDate: Thursday, July 23, 2026\n\nTime: 11:00 a.m. (Mexico City Time)\n\nWebcast: To register please access via direct link\n(https://edge.prnewswire.com/c/link/?t=0&l=en&o=4725665-1&h=3574173557&u=https%3A%2F%2Fmymottion.zoom.us%2Fwebinar%2Fregister%2FWN_i5P3wxtQTkCLK8g-R3HL9Q%23%2Fregistration&a=access+via+direct+link)\n\n            (You will receive an email confirmation with an invitation)\n\nAbout Genomma Lab Internacional\n\nGenomma Lab Internacional, S.A.B. de C.V. is one of the leading pharmaceutical\nand personal care products companies in Mexico with an increasing\ninternational presence. Genomma Lab develops, sells and markets a broad range\nof premium branded products, many of which are leaders in the categories in\nwhich they compete in terms of sales and market share. Genomma Lab relies on\nthe combination of a successful new product development process, a\nconsumer-oriented marketing, a broad retail distribution network and a\nlow-cost, highly flexible operating model.\n\nGenomma Lab's shares are listed on the Mexican Stock Exchange under the ticker\n\"LAB B\" (Bloomberg: LABB:MM).\n\nNote on Forward-Looking Statements\n\nThis report may contain certain forward-looking statements and information\nrelating to the Company that reflect the current views and/or expectations of\nthe Company and its management with respect to its performance, business and\nfuture events. Forward looking statements include, without limitation, any\nstatement that may predict, forecast, indicate or imply future results,\nperformance or achievements, and may contain words like \"believe,\"\n\"anticipate,\" \"expect,\" \"envisages,\" \"will likely result,\" or any other words\nor phrases of similar meaning. Such statements are subject to a number of\nrisks, uncertainties and assumptions. We caution you that a number of\nimportant factors could cause actual results to differ materially from the\nplans, objectives, expectations, estimates and intentions expressed in this\npresentation and in oral statements made by authorized officers of the\nCompany. Readers are cautioned not to place undue reliance on these\nforward-looking statements, which speak only as of their dates. The Company\nundertakes no obligation to update or revise any forward-looking statements,\nwhether as a result of new information, future events or otherwise.\n\nView original\ncontent:https://www.prnewswire.com/news-releases/genomma-lab-internacional-sab-de-cv-second-quarter-2026-earnings-results-conference-call-302818485.html\n(https://www.prnewswire.com/news-releases/genomma-lab-internacional-sab-de-cv-second-quarter-2026-earnings-results-conference-call-302818485.html)\n\nSOURCE Genomma Lab Internacional, S.A.B. de C.V.\n\n\n\nInvestor Relations, T. +52 (55) 5081 0000, investor.relations@genommalab.com\n\nCopyright (c) 2026 PR Newswire Association,LLC. All Rights Reserved."},"type":"article","timestamp":"2026-07-06T15:30:29.857824553Z","server_sent_at_ms":1783351829857},"received_at":"2026-07-06T15:30:29.923Z","source_url":"https://www.prnewswire.com/news-releases/genomma-lab-internacional-sab-de-cv-second-quarter-2026-earnings-results-conference-call-302818485.html"},"analysis":{"id":"70182","press_release_id":"81069","analysis_json":{"industry":{"label":"Pharmaceuticals, Biotechnology & Life Sciences","sector":"Health Care"},"redFlags":[],"eventType":"other","narrative":"Genomma Lab Internacional announced it will report its second quarter 2026 financial results on July 22, 2026, following the close of the Mexican Stock Exchange.\n\nManagement will host a conference call on July 23, 2026, at 11 a.m. Mexico City Time to discuss the quarterly performance, featuring CEO Marco Sparvieri and CFO Antonio Zamora.\n\nGenomma Lab is a pharmaceutical and personal care products company listed on the BMV under ticker LAB B.","sentiment":"neutral","agentHooks":{"shouldPost":false,"suggestedAngle":"Earnings call scheduling announcement; no new financial data."},"keyFigures":{},"quotedText":"","namedEntities":{"people":[{"name":"Marco Sparvieri","role":"Chief Executive Officer"},{"name":"Antonio Zamora","role":"Chief Financial Officer"},{"name":"Christianne Ibañez","role":"Investor Relations Officer"}],"products":[],"companies":[{"name":"Genomma Lab Internacional, S.A.B. de C.V.","ticker":"LABB"},{"name":"Mexican Stock Exchange","relationship":"listing exchange"}],"dollarAmounts":[]},"materialImpact":{"score":1,"reasoning":"Routine scheduling announcement for an upcoming earnings release and conference call; no financial results or material business developments disclosed."},"tickerRelevance":{"others":[],"primary":"LABB"},"globalImportance":10,"audienceRelevance":15,"eventTypeSecondary":[],"importanceComponents":{"tickerTier":"mid-cap-foreign","eventGravity":"administrative_scheduling","sectorWeight":"health_care"}},"event_type":"other","event_type_secondary":null,"sentiment":"neutral","material_impact_score":1,"narrative":"Genomma Lab Internacional announced it will report its second quarter 2026 financial results on July 22, 2026, following the close of the Mexican Stock Exchange.\n\nManagement will host a conference call on July 23, 2026, at 11 a.m. Mexico City Time to discuss the quarterly performance, featuring CEO Marco Sparvieri and CFO Antonio Zamora.\n\nGenomma Lab is a pharmaceutical and personal care products company listed on the BMV under ticker LAB B.","key_figures":{},"named_entities":{"people":[{"name":"Marco Sparvieri","role":"Chief Executive Officer"},{"name":"Antonio Zamora","role":"Chief Financial Officer"},{"name":"Christianne Ibañez","role":"Investor Relations Officer"}],"products":[],"companies":[{"name":"Genomma Lab Internacional, S.A.B. de C.V.","ticker":"LABB"},{"name":"Mexican Stock Exchange","relationship":"listing exchange"}],"dollarAmounts":[]},"model_name":"qwen3_6_27b_awq","prompt_hash":"sha256:727b4b9429a443af","schema_hash":"sha256:05005c02d9cffac9","created_at":"2026-07-06T15:32:17.388Z","global_importance":10,"audience_relevance":15,"importance_components":{"tickerTier":"mid-cap-foreign","eventGravity":"administrative_scheduling","sectorWeight":"health_care"}},"durationMs":107455,"modelName":"george-droid-qwen-72b"}}